Literature DB >> 8722876

Arthroscopy of the calcaneocuboid and talonavicular joints.

L Oloff1, S D Schulhofer, G Fanton, M Dillingham.   

Abstract

The authors describe the anatomy, portal placement, technique, indications, and preliminary results of seven cases of calcaneocuboid or talonavicular joint pathology that underwent elective investigational diagnostic or therapeutic arthroscopy with a follow up of 3-14 months. All patients had failed available conservative therapy. Results of treatment were five excellent and two good cases. Two patients required arthrotomy. There were no complications associated with portal placement, arthroscopic technique, or instrumentation. Arthroscopy of the calcaneocuboid and talonavicular joints has proven to be a relatively safe and valuable diagnostic and therapeutic tool. It is hoped that advances in small joint arthroscopy application will encourage further technological evolution in arthroscopic instrumentation and establish a foundation for further arthroscopic exploration of the small joints of the foot.

Entities:  

Mesh:

Year:  1996        PMID: 8722876     DOI: 10.1016/s1067-2516(96)80025-1

Source DB:  PubMed          Journal:  J Foot Ankle Surg        ISSN: 1067-2516            Impact factor:   1.286


  4 in total

1.  Arthroscopic Triple Arthrodesis in Management of Chronic Flatfoot Deformity.

Authors:  Tun Hing Lui
Journal:  Arthrosc Tech       Date:  2017-06-26

2.  Posterior Tibial Tendoscopy: Endoscopic Synovectomy and Assessment of the Spring (Calcaneonavicular) Ligament.

Authors:  Tun Hing Lui
Journal:  Arthrosc Tech       Date:  2015-12-14

3.  Safety and efficacy of talonavicular arthroscopy in arthroscopic triple arthrodesis. A cadaveric study.

Authors:  Tun Hing Lui; L K Chan
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-03-09       Impact factor: 4.342

4.  Arthroscopic management of late complications of calcaneal fractures.

Authors:  T H Lui; K B Chan
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-06-13       Impact factor: 4.342

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.